Insider Shareholders with Direct Ownership of Kairos Pharma, Ltd. (KAPA)
This section provides a comprehensive overview of the insiders with direct ownership of Kairos Pharma, Ltd. (KAPA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Kairos Pharma, LTD. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Neil Bhowmick
Chief Scientific Officer |
185,756 | 0 | 1,311,739 | 2 |
Oct 08, 2025
Added 11.58%
|
|
Ramachandran Murali
VP of Research and Development |
166,872 | 0 | 299,529 | 3 |
Oct 08, 2025
Added 33.76%
|
|
Doug Samuelson
Chief Financial Officer |
155,172 | 0 | 293,039 | 2 |
Oct 08, 2025
Added 34.25%
|
|
John S Yu
CEO and Chairman |
208,840 | 0 | 230,105 | 3 |
Oct 08, 2025
Added 45.34%
|
|
Hyun W. Bae
Director |
29,084 | 0 | 73,370 | 2 |
Oct 08, 2025
Added 20.64%
|
|
Rahul Singhvi
Director |
19,084 | 0 | 49,204 | 1 |
Oct 08, 2025
Added 27.95%
|
|
Hansoo Michael Keyoung
Director |
29,084 | 0 | 29,084 | 2 |
Oct 08, 2025
Added 39.62%
|